XML 26 R15.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2021
Fair Value Measurements  
Fair Value Measurements

Note 9—Fair Value Measurements

A reconciliation of the beginning and ending balances of the derivative liabilities is summarized below:

Beginning of period

    

    

Warrant liabilities – Public

 

21,390,000

Warrant liabilities – Private

 

11,449,330

Forward purchase agreement

 

7,692,950

Beginning of period total

$

40,532,280

Change in fair value of warrant liabilities – Public

 

(9,246,000)

Change in fair value of warrant liabilities – Private

 

(4,949,060)

Change in fair value of forward purchase agreement

 

(6,935,120)

End of period

$

19,402,100

The following tables present information about the Company’s financial assets that are measured at fair value on a recurring basis as of March 31, 2021 and December 31, 2020, respectively, by level within the fair value hierarchy:

Fair Value Measured as of March 31, 2021

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets:

Investments held in Trust Account

$

414,080,084

$

$

$

414,080,084

Liabilities:

Derivative liabilities - public warrants

$

12,144,000

$

$

$

12,144,000

Derivative liabilities - private placement warrants

$

$

6,500,270

$

$

6,500,270

Derivative liabilities - forward purchase agreement

$

$

$

757,830

$

757,830

Total liabilities

$

12,144,000

$

6,500,270

$

757,830

$

19,402,100

    

Fair Value Measured as of December 31, 2020

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets:

 

  

 

  

Investments held in Trust Account

 

$

414,020,525

$

$

$

414,020,525

Liabilities:

Derivative liabilities - public warrants

$

$

$

21,390,000

$

21,390,000

Derivative liabilities - private placement warrants

 

$

$

 

$

11,449,330

$

11,449,330

Derivative liabilities - forward purchase agreement

$

$

$

7,692,950

$

7,692,950

Total liabilities

 

$

$

$

40,532,280

$

40,532,280

Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement and the estimated fair value of the Private Placement Warrants transferred from a Level 3 measurement to a Level 2 fair value measurement, as a result of the Public Warrants being listed price in an active in February 2021.

Prior to the Public Warrants being separately traded in an active market, the fair value of the Public Warrants issued in connection with the Public Offering and the Private Placement Warrants were measured using a binomial lattice model in a risk-neutral framework. The fair value of the forward purchase agreement is based on the fair value of the Company’s publicly traded Units on each valuation date, less the present value of the contractually stipulated forward price of $10.00. Beginning in February 2021, the fair value of the Public Warrants are determined based on the listed price in an active market for such warrants and the fair value of the Private Placement Warrants is estimated to be approximately equal to that of the Public Warrants given the low likelihood of the Company’s ordinary share price exceeding $18.00 by the start of the exercise period.

For the three months ended March 31, 2021, the Company recognized a non-operating gain in the unaudited condensed statement of operations resulting from a decrease in the fair value of derivative liabilities of approximately $21.1 million, which is presented as change in fair value of derivative liabilities in the accompanying unaudited condensed statement of operations.

The estimated fair value of the Private Placement Warrants and the Public Warrants, as of December 31, 2020 was determined using Level 3 inputs. The Company estimates the volatility of its ordinary share warrants based on implied volatility from historical volatility of select peer company’s ordinary shares that matches the expected remaining life of the warrants.

The following table provides quantitative information regarding Level 3 fair value measurements inputs as of each measurement date:

As of

As of

 

    

March 31, 2021

    

December 31, 2020

Share price, used in warrant valuations

    

n/a

$

10.02

Unit price, used in forward valuation

$

10.05

$

10.54

Exercise price, warrants

n/a

$

11.50

Exercise price, forward

$

10.00

$

10.00

Term (in years), used in warrant valuations

n/a

6.00

Term (in years), used in forward valuation

0.71

0.96

Volatility

n/a

21.00

%

Risk-free interest rate, used in warrant valuations

n/a

0.50

%

Risk-free interest rate, used in forward valuation

0.06

%

0.10

%

Expected dividends

n/a

n/a

The change in the fair value of the derivative warrant liabilities, classified as Level 3, for the period for the three months ended March 31, 2021 is summarized as follows:

Level 3 derivative liabilities at December 31, 2020

$

40,532,280

Transfers out of Level 3

(32,839,330)

Change in fair value

(6,935,120)

Level 3 derivative liabilities at March 31, 2021

$

757,830